Page last updated: 2024-08-21

arsenic trioxide and Blast Phase

arsenic trioxide has been researched along with Blast Phase in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's5 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
del Rincon, SV; Diaz, Z; Garnier, N; Gupta, A; Kourelis, M; Kwan, S; Mann, KK; Miller, WH; Molina, MF; Petruccelli, LA; Schipper, HM1
Baumann, H; Brady, MT; Ford, LA; Lee, KP; Miller, A; Minderman, H; Sait, SN; Wang, ES; Wetzler, M1
Kashimura, M; Ohyashiki, K1
Canestraro, M; Cine, N; Galimberti, S; Guerrini, F; Metelli, MR; Nagy, B; Palumbo, GA; Petrini, M; Piaggi, S; Savli, H; Tibullo, D1
Bao, Y; Duan, Y; Kong, J; Liu, Z; Ma, X; Shan, B; Wang, Y; Wu, X1
Aleskog, A; Barbany, G; Bengtsson, M; Björnberg, A; Höglund, M; Larsson, R; Lindhagen, E; Olsson-Strömberg, U; Simonsson, B1
Altman, JK; Carayol, N; Dolniak, B; Fukunaga, R; Katsoulidis, E; Platanias, LC; Redig, AJ; Tallman, MS; Ueda, T; Watanabe-Fukunaga, R1
Brüggenolte, N; Güller, S; Hoelzer, D; Orleth, A; Ottmann, OG; Puccetti, E; Ruthardt, M1

Other Studies

8 other study(ies) available for arsenic trioxide and Blast Phase

ArticleYear
The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cells.
    Leukemia, 2013, Volume: 27, Issue:11

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Blast Crisis; Blotting, Western; Cell Cycle; Cell Proliferation; Chromatin Immunoprecipitation; Cytoprotection; DNA Helicases; Flow Cytometry; Glutathione; Heme Oxygenase-1; Humans; Leukemia, Promyelocytic, Acute; NF-E2-Related Factor 2; Nuclear Proteins; Oxides; Phosphorylation; Promoter Regions, Genetic; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factors; Tumor Cells, Cultured

2013
Down-regulation of signal transducer and activator of transcription 3 improves human acute myeloid leukemia-derived dendritic cell function.
    Leukemia research, 2013, Volume: 37, Issue:7

    Topics: Aminosalicylic Acids; Antigen-Presenting Cells; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Benzenesulfonates; Blast Crisis; Blotting, Western; Dendritic Cells; Down-Regulation; Endocytosis; Enzyme-Linked Immunosorbent Assay; Humans; Immunophenotyping; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Lymphocyte Activation; Oxides; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; T-Lymphocytes; Tumor Cells, Cultured

2013
Successful imatinib and arsenic trioxide combination therapy for sudden onset promyelocytic crisis with t(15;17) in chronic myeloid leukemia.
    Leukemia research, 2010, Volume: 34, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Benzamides; Blast Crisis; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oxides; Piperazines; Prognosis; Pyrimidines; Translocation, Genetic

2010
Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders.
    Cancer genetics and cytogenetics, 2010, Volume: 199, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Blast Crisis; Blotting, Western; Boronic Acids; Bortezomib; Caspase 8; Cell Cycle; Cell Proliferation; Drug Synergism; Gene Expression Profiling; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Myeloproliferative Disorders; NF-kappa B; Oligonucleotide Array Sequence Analysis; Oxides; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; TNF-Related Apoptosis-Inducing Ligand

2010
AID expression is correlated with Bcr-Abl expression in CML-LBC and can be down-regulated by As2O3 and/or imatinib.
    Leukemia research, 2011, Volume: 35, Issue:10

    Topics: Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Benzamides; Blast Crisis; Blotting, Western; Cells, Cultured; Cytidine Deaminase; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Female; Fusion Proteins, bcr-abl; Gene Expression; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytes, Mononuclear; Male; Middle Aged; Mutation; Oxides; Piperazines; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction

2011
Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
    Anti-cancer drugs, 2006, Volume: 17, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Benzamides; Blast Crisis; Cytarabine; Daunorubicin; Feasibility Studies; Harringtonines; Homoharringtonine; Humans; Imatinib Mesylate; In Vitro Techniques; Interferons; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oxides; Piperazines; Pyrimidines; Vincristine

2006
Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2.
    The Journal of biological chemistry, 2008, May-02, Volume: 283, Issue:18

    Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Blast Crisis; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Enzyme Activation; Enzyme Inhibitors; Eukaryotic Initiation Factor-4E; Fibroblasts; Gene Targeting; Humans; Intracellular Signaling Peptides and Proteins; Leukemia, Promyelocytic, Acute; Mice; Mitogen-Activated Protein Kinases; Oxides; Phosphorylation; Protein Serine-Threonine Kinases; Tumor Stem Cell Assay

2008
BCR-ABL mediates arsenic trioxide-induced apoptosis independently of its aberrant kinase activity.
    Cancer research, 2000, Jul-01, Volume: 60, Issue:13

    Topics: Antigens, CD34; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blast Crisis; Cells, Cultured; Colony-Forming Units Assay; Fusion Proteins, bcr-abl; Hematopoietic Stem Cells; Humans; Jurkat Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oxides; Philadelphia Chromosome; Proto-Oncogene Proteins c-abl; Tumor Cells, Cultured; U937 Cells

2000